The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
trimethobenzamide hydrochloride · Injection
3 marketed package NDCs · 3 active manufacturers
Most dispensed: 300 mg · Capsule · #30 capsules/package
Same drug class
Other molecules FDA puts in Antiemetic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- caffeine anhydrous, meclizine hydrochloride hydrate, pyridoxine hydrochloride· 1 maker
- meclazine hydrochloride tablet· 1 maker
- meclizine hcl 12.5mg· 1 maker
- meclizine hcl 25 mg· 1 maker
- tigan(r) (trimethobenzamide hydrochloride)· 1 maker
- meclizine hcl 25mg· 3 makers
- meclizine hcl 25mg chewable tablets· 3 makers
- meclizine hydrochloride chewable· 4 makers
- meclizine hcl 12.5 mg· 6 makers
- meclizine hydrocloride· 7 makers
- meclizine· 10 makers
- meclizine hcl· 33 makers
Common questions
- Is Trimethobenzamide hydrochloride in shortage right now?
- No. FDA does not currently list Trimethobenzamide hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Trimethobenzamide hydrochloride?
- 8 companies have marketed Trimethobenzamide hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.